## DOCU: DocuSign, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.41 indicates fundamental undervaluation. Quality metrics strong (ROE 15%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-4.5% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($60.57)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. DocuSign Stock Slides As Q3 Earnings Beat Fails To Impress**
- Source: Benzinga | 20251205T034400 | Somewhat-Bearish | Relevance: 100%
- DocuSign (NASDAQ: DOCU) reported strong third-quarter financial results, beating analyst estimates for both revenue and earnings per share. Despite the earnings beat and increased full-year guidance, the stock experienced a downturn in after-hours trading. The company highlighted growing customer investment in its IAM platform and robust profitability for the quarter.

**2. DocuSign: Fiscal Q3 Earnings Snapshot**
- Source: WHAS11 | 20251204T161300 | Bullish | Relevance: 100%
- DocuSign Inc. (DOCU) reported fiscal third-quarter net income of $83.7 million, or 40 cents per share, exceeding Wall Street expectations. Adjusted earnings were $1.01 per share. The company also surpassed revenue forecasts, posting $818.4 million for the quarter, and provided optimistic revenue guidance for the current quarter and full fiscal year.

**3. DocuSign in focus as analysts cut price targets despite 'solid' results (DOCU:NASDAQ)**
- Source: Seeking Alpha | 20251205T083800 | Somewhat-Bearish | Relevance: 100%
- DocuSign (DOCU) shares dropped despite reporting "solid" third-quarter results and guidance because Wall Street firms cut their price targets. The company exceeded analyst expectations for adjusted EPS and revenue, and it raised its full-year revenue forecast to $3.208B-$3.212B. However, the conservative outlook from analysts led to a decline in stock price.

**4. Docusign Announces Third Quarter Fiscal 2026 Financial Results**
- Source: PR Newswire | 20251204T160500 | Bullish | Relevance: 100%
- Docusign (NASDAQ: DOCU) announced strong financial results for its third quarter fiscal 2026, ending October 31, 2025, with revenue of $818.4 million, an 8% year-over-year increase, and non-GAAP diluted earnings per share of $1.01. The company highlighted growth in its Intelligent Agreement Management (IAM) platform, now serving over 25,000 customers, and provided optimistic guidance for the upcoming quarter and full fiscal year 2026.

**5. Docusign Inc (DOCU) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...**
- Source: Yahoo Finance | 20251204T090100 | Somewhat-Bullish | Relevance: 100%
- Docusign Inc (DOCU) reported strong Q3 2026 results with an 8% year-over-year revenue increase to $818 million and a 25% year-over-year free cash flow growth. The company achieved a non-GAAP operating margin of 31% and significantly expanded its Intelligent Agreement Management (IAM) platform customer base. Despite challenges like renewal timing variability and cloud migration costs impacting gross margin, Docusign provided optimistic guidance for both Q4 and fiscal year 2026 revenue and billings growth.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 8)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Piper Sandler | $75 | $90 | -17% |
| 2025-12-05 | UBS | $75 | $85 | -12% |
| 2025-12-05 | Evercore ISI Gr | $80 | $92 | -13% |
| 2025-12-05 | Wells Fargo | $75 | $85 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | UBS | main | Neutral |
| 2025-12-05 | Evercore ISI Gr | main | In-Line |
| 2025-12-05 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.01M) |
| Sells | 17 ($1.71M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 4 |

**Top Holders:**
- Blackrock Inc.: 11.8% (-2.8%)
- Vanguard Group Inc: 10.8% (+1.1%)
- State Street Corpora: 4.0% (+0.5%)
- Jericho Capital Asse: 2.4% (0.0%)
- Capital World Invest: 2.1% (+0.2%)

### Key Risks

1. Long-term trend broken: trading 14.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.41 indicates undervaluation relative to growth. Analyst sentiment negative (8 target cuts vs 0 raises). Insider selling cluster ($1.7M in 90 days), potential headwind. Institutional flow bearish (4 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $14.0B |
| Beta | 0.99 |
| 52W Range | $63.41 - $99.30 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.41 |
| Forward P/E | 16.0 |
| Current P/E | 17.4 |
| YoY Growth | 8.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.7% to -5.2% (-4.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.2pp (needs >4.0% for momentum thesis). Underperforming sector by 5.5pp, stock-specific weakness. Below SMA200 (0.85x), long-term trend not supportive. RSI neutral at 42. Elevated volume (2.9x 20MA), institutional activity likely. OFD pattern: +SBH (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.15% (CS: 11) | Weak |
| RSI_14 | 41.5 | Neutral |
| MACD Histogram | 0.37 | Bullish |
| vs SMA20 | 0.970x | Below |
| vs SMA50 | 0.942x | Below |
| vs SMA200 | 0.851x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $65.67
- **Stop Loss:** $60.57 (7.8% risk)
- **Target:** $75.87 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 196
- **Position Value:** $12,871.32
- **Portfolio %:** 12.87%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-03-12 (Est: $0.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.92 | $1.01 | +10.3% |
| 2025Q3 | $0.85 | $0.92 | +8.6% |
| 2025Q2 | $0.81 | $0.90 | +10.4% |
| 2025Q1 | $0.85 | $0.86 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*